Significant Ownership of NORTHSTRIVE FUND II LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for NORTHSTRIVE FUND II LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Braeden Lichti - Braeden Lichti/Manager
- Manager location
- Newport Beach, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow NORTHSTRIVE FUND II LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from NORTHSTRIVE FUND II LP
Significant Ownership of NORTHSTRIVE FUND II LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | Common Stock, par value $0.00001 per share | 5% | $331,842 | 33,151 | 0% | Braeden Lichti | 20 Feb 2026 | |
| ENVB | ENVERIC BIOSCIENCES, INC. | Common Stock, $0.01 par value per share | 0% | $0 | -$163,363 | 0 | -100% | Northstrive Fund II LP | 09 Dec 2025 |
| BJDX | Bluejay Diagnostics, Inc. | Common Stock, $0.0001 par value per share | 0% | $0 | -$68,160 | 0 | -100% | NorthStrive Fund II LP | 02 Jun 2026 |
Schedules 13D/G Reported by NORTHSTRIVE FUND II LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.